Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06229119 · ClinicalTrials.gov registry record · Phase 4
Vault Evaluation After ICL Implantation
A Phase 4 study of Nearsightedness, sponsored by Carolina Eyecare Physicians.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06229119 is a Phase 4 study of Nearsightedness that has completed, run by Carolina Eyecare Physicians. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06229119, a Phase 4 study of Nearsightedness, has completed, sponsored by Carolina Eyecare Physicians.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the lens vault after implantation of an implantable collamer lens (ICL). The ICL is designed to be implanted in front of the eye, without removing the natural lens. Because of this, it is also known as a phakic IOL. The ICL has already been approved by the U.S. Food and Drug Administration (FDA) to treat mid to high degrees of refractive errors such nearsightedness (also called myopia) with or without astigmatism. Once the artificial lens is implanted, a space between the ICL and the crystalline lens is created, which is called vault.
Conditions Studied
Interventions
- DEVICE Implantable Collamer Lens
Study Locations (1)
South Carolina
- Helga Sandoval - Mt. Pleasant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-01-29 |
| Est. Completion | 2024-08-23 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06229119
The ClinicalTrials.gov registry entry for NCT06229119 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carolina Eyecare Physicians, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nearsightedness appearing as the primary indexed condition, and to 1 intervention - of which Implantable Collamer Lens is the first listed.
NCT06229119 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT06229119 about?
NCT06229119 is a clinical study titled "Vault Evaluation After ICL Implantation". The purpose of this study is to evaluate the lens vault after implantation of an implantable collamer lens (ICL). The ICL is designed to be implanted in front of the eye, without removing the natural lens. Because of this, it is also known as a phakic IOL. The ICL has already been approved by the U....
What is the current status of trial NCT06229119?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2024-01-29. Estimated completion is 2024-08-23.
What conditions does trial NCT06229119 study?
This clinical trial studies the following conditions: Nearsightedness.
What interventions are being tested in trial NCT06229119?
The interventions under investigation include: Implantable Collamer Lens (DEVICE).
Who is sponsoring clinical trial NCT06229119?
This trial is sponsored by Carolina Eyecare Physicians, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06229119 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nearsightedness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.